INTERVENCION Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 166 participants.

Also called NCT02373163

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 166 participants (enrolled count) (from the registry)
Sponsor
Prevencion (from the registry)
Registry
  • NCT NCT02373163
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Peru (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02373163. Randomized; single masking; primary purpose treatment. Start 2014-09-01 (actual); primary completion 2016-03-01 (actual). Results posted on 2025-07-29.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
INTERVENCION Trial
Acronym
INTERVENCION
Condition
Blood Pressure, High
Intervention (Drug)
Hydrochlorothiazide
Intervention (Drug)
Amlodipine
Intervention (Drug)
Telmisartan
Lead sponsor
Prevencion (class: other)

Record details

Record id
cardio:ct-nct02373163
Content hash
774b9480a1bf1a38a962faa0bd3e786158583305d47adf1f01829c9610b21636